Skip to main content
. 2020 May 4;258:112932. doi: 10.1016/j.jep.2020.112932

Fig. 8.

Fig. 8

Molecular docking patterns of candidate compounds with SARS-COV-2 targets. A: Acetoside with 3CL; B: Glyasperin F with ACE2 stie 1; C: Isorhamnetin with ACE2 site 2.